Can I Take Berberine with NMN or NR (Nicotinamide Mononucleotide / Riboside)?
A guide to the pharmacokinetic and pharmacodynamic interactions between berberine and NMN/NR, including dosing timing, monitoring, and safety considerations.
A guide to the pharmacokinetic and pharmacodynamic interactions between berberine and NMN/NR, including dosing timing, monitoring, and safety considerations.
A guide to combining caffeine with NMN or NR supplements: mechanisms, pharmacokinetics, glucose and blood-pressure effects, dose-separation windows, and monitoring guidance.
A guide on the pharmacodynamic interaction between folate and NMN/NR supplements, covering methylation biology, MTHFR variants, dosing, monitoring, and when to separate doses.
What is known and not known about combining omega-3 fatty acids (EPA/DHA) with NAD+ precursor supplements (NMN or NR), including the antiplatelet caution, mechanistic overlap, and what to verify with a prescriber or pharmacist.
A clinical review of combining saw palmetto with NMN or NR supplements, covering pharmacokinetic and pharmacodynamic interactions, anticoagulant risks, 5-alpha-reductase inhibition, dosing guidance, and monitoring recommendations.
A guide to combining vitamin D with NMN or NR supplements, covering mechanisms, safety, dosing, and monitoring based on current clinical evidence.
A clinical review of the CoQ10 and oral minoxidil interaction, covering pharmacokinetics, blood pressure effects, safe dosing, and monitoring for hair loss patients.
A guide to combining glycine supplements with low-dose oral minoxidil for hair loss, covering pharmacokinetic interactions, sleep effects, glycemic considerations, and safe dosing protocols.
What evidence says about magnesium with oral minoxidil: elemental dose, supplement limits, blood pressure, kidney function and unanswered interaction questions.
A guide to the quercetin, oral minoxidil interaction: pharmacokinetics, CYP3A4 inhibition, antihypertensive overlap, safe dosing windows, and monitoring steps for patients taking low-dose oral minoxidil for hair loss.
A guide covering the pharmacokinetic and pharmacodynamic interactions between reishi mushroom and low-dose oral minoxidil for hair loss, including monitoring guidance and safety thresholds.
A guide covering the pharmacokinetic and pharmacodynamic interactions between ashwagandha (Withania somnifera) and semaglutide (Ozempic), including cortisol, thyroid, and blood-glucose effects, plus monitoring guidance.
A guide to combining NAC and semaglutide (Ozempic): pharmacokinetic and pharmacodynamic interactions, safety evidence, dosing considerations, and monitoring recommendations.
A guide to the reishi mushroom and Ozempic (semaglutide) interaction, covering mechanisms, blood sugar and bleeding risks, monitoring, and practical guidance for people with type 2 diabetes.
Vitamin B12 is safe to take with Ozempic (semaglutide). There is no pharmacokinetic interaction between the two. Learn why B12 monitoring matters on semaglutide, especially if you also use metformin, and how to supplement correctly.
A guide to the glutathione and pioglitazone combination: pharmacokinetic interactions, liver considerations, dosing windows, and monitoring steps for people managing type 2 diabetes or NASH.
A guide to taking glutathione with Prometrium (micronized progesterone), covering interaction mechanisms, liver detox pathways, dose timing, monitoring, and safety evidence.
A guide to the creatine-sirolimus interaction: what the evidence shows about creatinine elevation, renal monitoring, and how to take both safely.
A clinical review of the ginseng-sirolimus interaction: pharmacokinetic and pharmacodynamic risks, blood glucose effects, anticoagulant potentiation, monitoring guidance, and what to do if you are already taking both.
A clinically detailed guide to combining melatonin and sirolimus (Rapamycin): pharmacokinetic interactions, glucose effects, dosing windows, and monitoring guidance prepared by the HealthRX.com Editorial Team.
A guide to combining N-acetylcysteine (NAC) with rapamycin (sirolimus): pharmacokinetic interactions, pharmacodynamic combination or conflict, dosing windows, monitoring labs, and when to call your prescriber.
St. John's Wort powerfully induces CYP3A4 and P-glycoprotein, cutting sirolimus blood levels by up to 50%. Learn why this combination is contraindicated, what the pharmacokinetic data show, and what to do if you are already taking both.
A guide to the vitamin B12 and rapamycin (sirolimus) interaction: mechanism, monitoring, dosing, and safety evidence for transplant patients and longevity users.
A guide covering the pharmacokinetic and pharmacodynamic interactions between sirolimus and vitamin D, monitoring recommendations, and practical dosing guidance for transplant and longevity patients.
A guide to combining glutathione supplements with Rezdiffra (resmetirom) for MASH: interaction mechanisms, safety evidence, dosing timing, and monitoring recommendations.
A clinical review of vitamin B12 safety, interactions, and monitoring when combined with resmetirom (Rezdiffra) for MASH. Written by the HealthRX.com medical team.
A guide covering the pharmacodynamic and pharmacokinetic interaction between berberine and oral semaglutide (Rybelsus), including hypoglycemia risk, dosing strategy, and monitoring guidance.
A guide to the resveratrol-Rybelsus interaction: pharmacokinetics, CYP3A4 effects, absorption timing, monitoring, and safe use with oral semaglutide for type 2 diabetes.
What is established, what is plausible, and what is unverified about combining creatine monohydrate with sermorelin acetate, including renal-lab monitoring guidance and questions to raise with a prescriber.
A guide to combining N-acetylcysteine (NAC) with sermorelin acetate: mechanisms, pharmacokinetic vs pharmacodynamic interactions, dosing windows, and monitoring guidance.
A board-reviewed clinical guide on the sermorelin and St. John's Wort interaction, covering mechanism, pharmacokinetics, monitoring, and what to do if you're already taking both.
St. John's Wort is a potent CYP3A4 inducer that can cut sildenafil blood levels by up to 70%, making the drug far less effective. Learn the mechanism, the risk, and what to do if you are already taking both.
A guide to the vitamin B12 and sildenafil interaction, covering pharmacokinetics, real risks, dosing guidance, and monitoring advice for patients on sildenafil 20 to 100 mg.
A guide to the caffeine-spironolactone interaction: pharmacokinetics, blood pressure effects, potassium considerations, and practical safety advice for patients taking spironolactone for acne, hirsutism, or heart failure.
You can take creatine with spironolactone. Creatine raises serum creatinine without harming kidneys, so tell your prescriber and recheck labs at 4 weeks.
A clinical guide to the spironolactone-glutathione combination: mechanisms, interaction risk, dosing, monitoring, and what to tell your prescriber before combining both.
A guide to the spironolactone-glycine combination: what interactions exist, which are pharmacokinetic vs pharmacodynamic, how to monitor safely, and what remains unverified about combining the two.
A guide to the reishi mushroom and spironolactone interaction, covering pharmacokinetic and pharmacodynamic mechanisms, bleeding risk, potassium concerns, monitoring, and when to call your prescriber.
A guide to the spironolactone-resveratrol interaction: pharmacokinetics, estrogenic effects, potassium risks, and safe monitoring steps.
A guide to the spironolactone and saw palmetto interaction: mechanism, safety evidence, monitoring, and practical dosing guidance for hormonal acne patients.
St. John's Wort is a strong inducer of the CYP3A4 enzyme system. Because spironolactone depends heavily on CYP3A4 metabolism, combining the two may lower spironolactone's effective dose and blunt its benefit for hormonal acne, hirsutism, or blood pressure. Here is what is established, what is plausible but unproven, and what a clinician or pharmacist should verify.
A guide covering the pharmacokinetic and pharmacodynamic interactions between turmeric (curcumin) and spironolactone, with safety guidance for people using spironolactone for hormonal acne, hirsutism, or heart failure.
A guide covering the pharmacokinetic and pharmacodynamic interactions between ginseng and tadalafil 2.5 to 20 mg, including safety monitoring, dose timing, and when to call your prescriber.
A guide to the glutathione and tadalafil interaction: pharmacokinetics, safety evidence, dosing considerations, and when to consult your prescriber.
A guide to the NAC and tadalafil interaction: mechanism, safety data, dosing timing, monitoring, and when to ask your prescriber for guidance.
A guide to the omega-3 and tadalafil interaction: pharmacokinetics, antiplatelet risk, triglyceride effects, monitoring, and safe co-use at doses 2.5 to 20 mg.
A guide to the quercetin-tadalafil interaction: CYP3A4 inhibition, blood pressure risk, dose-separation strategies, and what to tell your prescriber.
A guide covering the pharmacodynamic and pharmacokinetic interaction between saw palmetto and tadalafil 2.5 to 20 mg, with dosing guidance, monitoring parameters, and safety thresholds.
A guide to the TB-500 and caffeine interaction, covering pharmacokinetics, pharmacodynamics, blood pressure effects, glucose considerations, and practical dosing guidance.
A clinical review of calcium and TB-500 (thymosin beta-4 active fragment) co-administration: known mechanisms, pharmacokinetic considerations, dose-separation windows, cardiovascular signals, and monitoring guidance.
A guide to combining glutathione with TB-500 (thymosin beta-4 active fragment): mechanisms, interaction risk, dosing windows, and monitoring guidance.
Separate magnesium nutrition from TB-500 research, including peptide identity, interaction evidence, and why timing claims are not established protocols.
A guide to taking melatonin alongside TB-500 (thymosin beta-4 active fragment): interaction type, dose timing, glucose monitoring, and safety considerations.
A guide to the pharmacodynamic and pharmacokinetic interaction between TB-500 (thymosin beta-4 active fragment) and vitamin B6, covering dose thresholds, neuropathy risk, monitoring, and clinical guidance.
What is known and not established about combining calcium supplements with Egrifta SV (tesamorelin) in HIV-associated lipodystrophy, including bone and IGF-1 considerations, and where a pharmacist should be consulted before dosing decisions.
A clinical review of glycine and tesamorelin (Egrifta) co-administration: mechanisms, interaction type, glycemic monitoring, dosing timing, and when to contact your prescriber.
A guide to combining lion's mane mushroom with tesamorelin (Egrifta), covering pharmacokinetic and pharmacodynamic interaction risks, NGF signaling overlap, bleeding considerations, and monitoring steps.
A board-reviewed guide to the magnesium, tesamorelin interaction: mechanism, safety evidence, monitoring parameters, and practical dosing guidance for HIV-associated lipodystrophy patients.
A guide to combining creatine with Testosterone Cypionate: mechanism, safety, creatinine lab interference, dosing, and monitoring protocols.
A clinical review of combining glycine supplementation with Testosterone Cypionate therapy, covering pharmacokinetic interactions, sleep effects, glycemic considerations, collagen support, dosing windows, and monitoring guidance.